Schaper Benz & Wise Investment Counsel Inc Johnson & Johnson Transaction History

Schaper Benz & Wise Investment Counsel Inc

  • $1.21 Billion
  • Q3 2024

A detailed history of Schaper Benz & Wise Investment Counsel Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Schaper Benz & Wise Investment Counsel Inc holds 97,483 shares of JNJ stock, worth $15.1 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
97,483
Previous 95,715 1.85%
Holding current value
$15.1 Million
Previous $14 Million 12.93%
% of portfolio
1.3%
Previous 1.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$145.48 - $167.38 $257,208 - $295,927
1,768 Added 1.85%
97,483 $15.8 Million
Q2 2024

Aug 07, 2024
SELL
$144.38 - $157.78 $71,612 - $78,258
-496 Reduced 0.52%
95,715 $14 Million
Q1 2024

Apr 29, 2024
BUY
$155.22 - $162.74 $624,450 - $654,703
4,023 Added 4.36%
96,211 $15.2 Million
Q4 2023

Feb 07, 2024
BUY
$145.6 - $158.88 $26,353 - $28,757
181 Added 0.2%
92,188 $14.4 Million
Q3 2023

Oct 11, 2023
SELL
$155.75 - $174.48 $175,841 - $196,987
-1,129 Reduced 1.21%
92,007 $14.3 Million
Q2 2023

Jul 17, 2023
BUY
$154.35 - $166.11 $52,479 - $56,477
340 Added 0.37%
93,136 $15.4 Million
Q1 2023

May 01, 2023
SELL
$151.05 - $180.26 $249,685 - $297,969
-1,653 Reduced 1.75%
92,796 $14.4 Million
Q4 2022

Jan 25, 2023
SELL
$160.2 - $179.79 $681,651 - $765,006
-4,255 Reduced 4.31%
94,449 $0
Q3 2022

Oct 17, 2022
SELL
$161.33 - $179.52 $437,849 - $487,217
-2,714 Reduced 2.68%
98,704 $16.1 Million
Q2 2022

Aug 04, 2022
SELL
$168.19 - $186.01 $1.54 Million - $1.7 Million
-9,131 Reduced 8.26%
101,418 $18 Million
Q1 2022

Apr 29, 2022
SELL
$158.14 - $179.59 $527,871 - $599,471
-3,338 Reduced 2.93%
110,549 $19.6 Million
Q4 2021

Feb 10, 2022
SELL
$155.93 - $173.01 $28,847 - $32,006
-185 Reduced 0.16%
113,887 $19.5 Million
Q3 2021

Oct 27, 2021
SELL
$161.5 - $179.47 $3,391 - $3,768
-21 Reduced 0.02%
114,072 $18.4 Million
Q2 2021

Jul 29, 2021
SELL
$159.48 - $171.07 $10,047 - $10,777
-63 Reduced 0.06%
114,093 $18.8 Million
Q1 2021

Apr 20, 2021
BUY
$153.07 - $170.48 $211,083 - $235,091
1,379 Added 1.22%
114,156 $18.8 Million
Q4 2020

Feb 11, 2021
SELL
$137.11 - $157.38 $73,902 - $84,827
-539 Reduced 0.48%
112,777 $17.7 Million
Q3 2020

Nov 05, 2020
BUY
$140.38 - $153.83 $32,848 - $35,996
234 Added 0.21%
113,316 $16.9 Million
Q2 2020

Jul 30, 2020
SELL
$128.81 - $155.51 $441,818 - $533,399
-3,430 Reduced 2.94%
113,082 $15.9 Million
Q1 2020

May 04, 2020
SELL
$111.14 - $153.99 $8,335 - $11,549
-75 Reduced 0.06%
116,512 $15.3 Million
Q4 2019

Jan 30, 2020
SELL
$127.5 - $146.44 $18,615 - $21,380
-146 Reduced 0.13%
116,587 $17 Million
Q3 2019

Nov 04, 2019
BUY
$126.95 - $142.14 $180,776 - $202,407
1,424 Added 1.23%
116,733 $15.1 Million
Q2 2019

Aug 05, 2019
SELL
$131.15 - $144.24 $188,200 - $206,984
-1,435 Reduced 1.23%
115,309 $16.1 Million
Q1 2019

Apr 23, 2019
BUY
$125.72 - $139.79 $78,323 - $87,089
623 Added 0.54%
116,744 $16.3 Million
Q4 2018

Feb 13, 2019
SELL
$122.84 - $147.84 $68,176 - $82,051
-555 Reduced 0.48%
116,121 $15 Million
Q3 2018

Oct 19, 2018
BUY
$121.58 - $142.88 $61,884 - $72,725
509 Added 0.44%
116,676 $16.1 Million
Q2 2018

Aug 06, 2018
BUY
$119.4 - $131.76 $477,958 - $527,435
4,003 Added 3.57%
116,167 $14.1 Million
Q1 2018

Apr 30, 2018
SELL
$125.1 - $148.14 $41,283 - $48,886
-330 Reduced 0.29%
112,164 $14.4 Million
Q4 2017

Jan 26, 2018
SELL
$131.22 - $143.62 $148,672 - $162,721
-1,133 Reduced 1.0%
112,494 $15.7 Million
Q3 2017

Nov 02, 2017
SELL
$129.47 - $135.38 $140,345 - $146,751
-1,084 Reduced 0.94%
113,627 $14.8 Million
Q2 2017

Aug 07, 2017
BUY
N/A
114,711
114,711 $15.2 Million

Others Institutions Holding JNJ

# of Institutions
4,271
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Schaper Benz & Wise Investment Counsel Inc Portfolio

Follow Schaper Benz & Wise Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email